The Priority Review

Tag

Enrollment

1 story

Stories

  1. Clinical trials

    Among industry trials that gave a stop reason, 6 in 10 now cite a sponsor or business decision, up from 3 in 10

    A Priority Review analysis of 18,422 terminated trials on ClinicalTrials.gov. Among industry trials that gave a stop reason, 63.5% of those ended in 2025 cited a sponsor or business decision (407 of 641), up from 31.5% in 2016 (107 of 340). Enrollment fell from 31.8% to 12.3% on the same basis.